In contrast, other studies have suggested that the effect of KIR-ligand incompatibility is not consistent, particularly as it relates to conditioning regimen, donor source and GVHD outcomes [11], [12], [13], [14]. The gene discussed is KIR3DL1; the disease is graft versus host disease.